Mr. Nelson Cabatuan resigned as the Chief Financial Officer of Lexaria Bioscience Corp. to focus on corporate finance and strategic industry relationships, with no disagreement or issues with the company. The company also announced initial results from an animal study showing the effectiveness of DehydraTECH with certain drugs.